Literature DB >> 6925441

Activation of the kallikrein-kinin system in premature infants with respiratory distress syndrome (RDS).

O D Saugstad, A Harvie, A Langslet.   

Abstract

Plasma prekallikrein levels, kallikrein activity and antikallikrein levels were investigated in nine premature infants with respiratory distress syndrome (RDS) and six premature infants without. Plasma prekallikrein and kallikrein were determined with a chromogenic substrate measuring amidolytic activity. Antikallikrein was measured with a functional assay. In infants with severe RDS, prekallikrein levels were significantly reduced (median 58% of initial values (p less than 0.01) about 48 hours after onset of symptoms. In infants with moderate RDS prekallikrein level was reduced less, while in babies without RDS there were no significant changes in prekallikrein levels the first 5-7 days of life. Antikallikrein levels did not change significantly in any babies. The results suggest that the kallikrein-kinin system might be involved in RDS. This could explain several features of this syndrome such as hypotension and edema. Furthermore the findings show that homeostatic functions are altered in this disease, and they suggest that other cascade systems as the coagulation, fibrinolytic and complement system may be involved as well. The findings emphasize that trauma might be a significant pathogenetical factor for development of this syndrome and indicate that RDS is not simply a biochemical disease with lack of surfactant as the only pathogenetic factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6925441     DOI: 10.1111/j.1651-2227.1982.tb09557.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  3 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Contact phase of blood coagulation in cardiogenic pulmonary oedema (CPO) and adult respiratory distress syndrome (ARDS).

Authors:  C Herrera; F Velasco; A Guerrero; R Guerrero; F Alvarez; A Torres
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Evaluation of complement activation in premature newborn infants with hyaline membrane disease.

Authors:  R Cat; N A Rosario; I T de Messias; T D Resener; M Kirschfink
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.